If Australia’s Flu Season Is Any Indication, U.S. Is In For A Long Winter
As flu season kicks off, health officials warn it may be severe this year. Also, Johns Hopkins researchers work to bring back the nasal spray version of the flu vaccine after it was sidelined due to ineffectiveness.
Los Angeles Times:
Australia's Flu Season Has U.S. Health Officials Bracing For A Bad Winter — And Wishing For A New Vaccine
The flu season is just getting underway in North America, but if Australia’s experience with influenza is any guide, we’re in for a miserable winter. Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, warned Wednesday that the United States could experience a “relatively severe influenza season.” If so, it would extend a run of bad luck that began in 2014, when the available flu vaccines proved to be a poor match for the most common viruses in circulation. (Healy, 11/29)
The Baltimore Sun:
Johns Hopkins Researchers Discover Mutation That May Be Key To Return Of Popular Nasal Spray Version Of Flu Vaccine
Johns Hopkins researchers believe they’ve figured out how to fix a popular nasal spray vaccine that federal authorities told people to stop using last year because it offered little protection from the flu. That would be welcome news for needle-averse children and adults who dread getting a shot even if it protects them against the respiratory virus that infects millions of Americans every year and can be dangerous for the elderly, chronically ill and very young. (Cohn, 11/29)
In other vaccine news -
Health News Florida:
Rapid Zika Test Possible For 2018
Hospitals and health departments could have a new tool in 2018 to detect Zika – a test that is cheap, portable and fast. The test involves a drop of blood, can get results in 20 minutes and doesn’t require blood be sent out to a lab. (Aboraya, 11/29)
Reuters:
New Vaccine, Long-Acting Drug Trials Buoy Hopes In HIV Fight
Researchers announced the launch of two big studies in Africa on Thursday to test a new HIV vaccine and a long-acting injectable drug, fueling hopes for better ways to protect against the virus that causes AIDS. (Hirschler, 11/30)
